Legal Representation
Attorney
Bradley P. Hartman
USPTO Deadlines
Next Deadline
656 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-04)
Due Date
May 04, 2027
Grace Period Ends
November 04, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 9, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 9, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 4, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 16, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 16, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 27, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 13, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 11, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 19, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 19, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 19, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 17, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 25, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 25, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Veterinary and scientific research in the field of genetic testing and diagnosis and treatment of veterinary conditions; Development of tests and laboratory testing in the field of genetics and animal disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Veterinary and scientific research, development and consulting in the field of oncology; Veterinary and scientific research and consulting in the fields of genomics and generation sequencing; Veterinary and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for scientific research purposes; Veterinary and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials for others; Conducting educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics for scientific purposes; Consulting services in the field of veterinary research of veterinary and genetic conditions; Diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids for scientific purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; DNA-sequencing for scientific research purposes; Targeted pharmaceutical drug development services; Genotyping for scientific purposes; Gene screening for scientific purposes; Gene isolation and gene expression analysis for scientific research purposes; Gene mapping for scientific purposes; Gene analysis and biomarker discovery for scientific research purposes
First Use Anywhere:
May 26, 2020
First Use in Commerce:
Jun 4, 2020
Class 044
Veterinary testing for diagnostic or treatment purposes in the field of cancer research; Veterinary diagnostic testing, monitoring and reporting services; Veterinary evaluation services; Veterinary monitoring services; Veterinary diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for veterinary diagnostic or treatment purposes; Consulting services in the nature of providing veterinary information; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for veterinary diagnostic or treatment purposes; Providing information in the field of screening, diagnosis and treatment for veterinary diagnostic and treatment purposes; Genetic testing for veterinary diagnostic purposes; Genomic testing for veterinary diagnostic purposes
First Use Anywhere:
May 26, 2020
First Use in Commerce:
Jun 4, 2020
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ANIMAL HEALTH"